California State Teachers Retirement System lowered its position in shares of Orthofix International N.V. (NASDAQ:OFIX) by 11.6% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 30,512 shares of the medical device company’s stock after selling 4,000 shares during the period. California State Teachers Retirement System owned 0.17% of Orthofix International N.V. worth $1,418,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently added to or reduced their stakes in OFIX. Pinebridge Investments L.P. grew its position in Orthofix International N.V. by 2.3% in the 2nd quarter. Pinebridge Investments L.P. now owns 2,378 shares of the medical device company’s stock valued at $111,000 after buying an additional 53 shares in the last quarter. Arizona State Retirement System grew its position in Orthofix International N.V. by 1.1% in the 2nd quarter. Arizona State Retirement System now owns 9,400 shares of the medical device company’s stock valued at $437,000 after buying an additional 100 shares in the last quarter. Victory Capital Management Inc. grew its position in Orthofix International N.V. by 1.2% in the 2nd quarter. Victory Capital Management Inc. now owns 32,089 shares of the medical device company’s stock valued at $1,491,000 after buying an additional 365 shares in the last quarter. AJO LP grew its position in Orthofix International N.V. by 0.4% in the 2nd quarter. AJO LP now owns 169,162 shares of the medical device company’s stock valued at $7,863,000 after buying an additional 702 shares in the last quarter. Finally, Voya Investment Management LLC grew its position in Orthofix International N.V. by 10.7% in the 2nd quarter. Voya Investment Management LLC now owns 8,622 shares of the medical device company’s stock valued at $401,000 after buying an additional 832 shares in the last quarter. Institutional investors and hedge funds own 93.80% of the company’s stock.

A number of equities analysts recently issued reports on OFIX shares. BidaskClub lowered shares of Orthofix International N.V. from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, July 25th. Zacks Investment Research upgraded shares of Orthofix International N.V. from a “hold” rating to a “buy” rating and set a $54.00 target price for the company in a research report on Thursday, August 10th. TheStreet upgraded shares of Orthofix International N.V. from a “c+” rating to a “b-” rating in a research report on Tuesday, August 8th. Jefferies Group LLC reiterated a “buy” rating and issued a $55.00 target price (up previously from $50.00) on shares of Orthofix International N.V. in a research report on Thursday, August 10th. Finally, BTIG Research set a $56.00 target price on shares of Orthofix International N.V. and gave the company a “buy” rating in a research report on Monday, October 30th. One equities research analyst has rated the stock with a hold rating and six have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $54.42.

In other Orthofix International N.V. news, insider Bradley V. Niemann sold 6,956 shares of the company’s stock in a transaction dated Monday, September 11th. The shares were sold at an average price of $49.44, for a total value of $343,904.64. Following the completion of the sale, the insider now directly owns 40,178 shares of the company’s stock, valued at approximately $1,986,400.32. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Luke T. Faulstick sold 4,800 shares of the company’s stock in a transaction dated Monday, November 6th. The shares were sold at an average price of $51.22, for a total transaction of $245,856.00. Following the completion of the sale, the director now directly owns 7,729 shares of the company’s stock, valued at $395,879.38. The disclosure for this sale can be found here. Insiders sold a total of 19,109 shares of company stock valued at $953,440 over the last three months. 5.60% of the stock is owned by corporate insiders.

ILLEGAL ACTIVITY WARNING: This news story was reported by Watch List News and is the sole property of of Watch List News. If you are accessing this news story on another publication, it was copied illegally and reposted in violation of international trademark and copyright laws. The legal version of this news story can be read at https://www.watchlistnews.com/california-state-teachers-retirement-system-sells-4000-shares-of-orthofix-international-n-v-ofix/1717252.html.

Orthofix International N.V. (NASDAQ:OFIX) opened at $53.29 on Tuesday. The stock has a market cap of $972.99, a PE ratio of 34.88, a P/E/G ratio of 2.65 and a beta of 0.15. Orthofix International N.V. has a 12-month low of $32.51 and a 12-month high of $54.33.

Orthofix International N.V. (NASDAQ:OFIX) last issued its quarterly earnings results on Monday, October 30th. The medical device company reported $0.42 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.41 by $0.01. Orthofix International N.V. had a net margin of 0.33% and a return on equity of 10.26%. The company had revenue of $105.30 million during the quarter, compared to the consensus estimate of $100.67 million. During the same period in the prior year, the company earned $0.36 EPS. Orthofix International N.V.’s revenue was up 6.9% on a year-over-year basis. sell-side analysts expect that Orthofix International N.V. will post 1.61 earnings per share for the current year.

Orthofix International N.V. Company Profile

Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.

Institutional Ownership by Quarter for Orthofix International N.V. (NASDAQ:OFIX)

Receive News & Ratings for Orthofix International N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International N.V. and related companies with Analyst Ratings Network's FREE daily email newsletter.